Company Filing History:
Years Active: 1999-2003
Title: Innovations by Adrienne P Smyth
Introduction
Adrienne P Smyth is a notable inventor based in Charlton, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides for therapeutic applications. With a total of 3 patents, her work focuses on innovative solutions for various medical disorders.
Latest Patents
One of her latest patents is titled "Modified VEGF Oligonucleotides for Inhibition of Tumor Growth." This invention discloses oligonucleotides that are complementary to VEGF-specific nucleic acids, which are useful in reducing the expression of VEGF. Additionally, it includes pharmaceutical formulations containing these oligonucleotides that are beneficial for treating disorders associated with neovascularization and angiogenesis. Another significant patent is "Modified VEGF Oligonucleotides for Treatment of Skin Disorders." This patent also discloses oligonucleotides that reduce the expression of VEGF and includes formulations for treating various skin disorders, including psoriasis.
Career Highlights
Adrienne P Smyth is currently associated with Hybridon, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in paving the way for new therapeutic approaches in the medical field.
Collaborations
One of her notable coworkers is Gregory S Robinson, who collaborates with her on various projects within the company.
Conclusion
Adrienne P Smyth's innovative contributions to biotechnology, particularly in the area of VEGF oligonucleotides, highlight her role as a leading inventor in her field. Her patents reflect her commitment to advancing medical science and improving treatment options for patients.